Prices delayed by at least 15 minutes | Print
Skinbiotherapeutics PLC (SBTX)
ORD 1POpen
25.25p
Previous close
25.25p
Trade high
27.50p
Volume
1,189,996
Year high
27.50p
Year low
0.2425p
Dividend yield
–
Market capitalisation
£60.55 mn
P/E ratio
–
ISIN
GB00BF33H870
This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Share price
Company profile
SkinBioTherapeutics PLC is a life science company focused on skin health. It is focused on the development of technology to protect, manage, and restore skin utilizing proteins found in the human microbiota. It is targeting three specific skin healthcare sectors; cosmetics, infection control, and eczema.
News
Recent trades
| Date | Time | Price | Quantity | Value (£) |
|---|---|---|---|---|
| 25/04/2025 | 05:08:31 | 26.1 | 5,000 | 1,305.00 |
| 25/04/2025 | 04:35:06 | 26.1 | 17,695 | 4,618.40 |
| 25/04/2025 | 04:11:18 | 26.47 | 10,000 | 2,647.00 |
| 25/04/2025 | 03:58:47 | 26.47 | 7,555 | 1,999.81 |
| 25/04/2025 | 03:52:27 | 26.47 | 9,800 | 2,594.06 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.